跳至主要内容
临床试验/NCT00727493
NCT00727493Unknown4 期

Evaluation of the Influence of Alendronate on Wound Healing After Dental Implants in Patients With Osteoporosis

Charite University, Berlin, Germany1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2004年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
45
试验地点
1
主要终点
Dental CT

研究概览

简要总结

The purpose of this study is to evaluate the influence of alendronate therapy on the wound healing after dental implants in patients with osteoporosis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
60 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Postmenopausal women > 2 years after menopause
  • Age between 60 and 75 years
  • Possibility to insert a dental implant
  • Osteoporosis as defined by WHO criteria (intervention group), or women without osteoporosis / osteopenia (non-intervention group)

排除标准

  • Pathological findings in the jaw bone
  • Chronic inflammatory rheumatoid disease
  • Bisphosphonate treatments during the last 12 months
  • Inflammatory or metabolic bone disease, excluding osteoporosis
  • Systemic corticosteroid treatments of more than one month within previous 12 months
  • Severe diseases with life expectancy less than one year or expectation of rapid worsening within one year

研究组 & 干预措施

1

Active Comparator

alendronate once weekly 70mg, calcium 1000mg and Vitamin D 800 IU daily, dental implant

干预措施: alendronate once weekly 70mg (Drug)

2

Placebo Comparator

placebo once weekly, calcium 1000mg and Vitamin D 800 IU daily; dental implant

干预措施: placebo (Drug)

结局指标

主要结局

Dental CT

时间窗: baseline, and 3,6,12 months after baseline

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Osteoporosis and Dental Implant | 临床试验